United States - English - NLM (National Library of Medicine)

e.r. squibb & sons, l.l.c. - belatacept (unii: e3b2gi648a) (belatacept - unii:e3b2gi648a) - belatacept 250 mg - nulojix® (belatacept) is indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant. nulojix is to be used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids. use nulojix only in patients who are ebv seropositive [see contraindications (4) and warnings and precautions (5.1)] . use of nulojix for the prophylaxis of organ rejection in transplanted organs other than kidney has not been established [see warnings and precautions (5.6)] . nulojix is contraindicated in transplant recipients who are epstein-barr virus (ebv) seronegative or with unknown ebv serostatus due to the risk of post-transplant lymphoproliferative disorder (ptld), predominantly involving the central nervous system (cns) [see boxed warning and warnings and precautions (5.1)] . to monitor maternal-fetal outcomes of pregnant women who have received immunosuppressants including nulojix or whose partners have received nulojix, healthcare providers are strongly encouraged to regis

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - belatacept, quantity: 250 mg - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; monobasic sodium phosphate; sucrose; nitrogen; sodium hydroxide; sodium chloride - nulojix (belatacept) is indicated for prophylaxis of organ rejection in adults receiving a renal transplant. nulojix is to be used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids.

European Union - English - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressants - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant. 

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - belatacept - powder for solution for infusion - 250mg

United States - English - NLM (National Library of Medicine)

tonghua ren-sheng-yuan biotechnology co., ltd - gastrodia elata whole (unii: zk2b063e7q) (gastrodia elata whole - unii:zk2b063e7q), alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. used for hand sanitizing and surgical hand sanitizing. - on children less than 2 months of age - on open skin wounds - in the eyes. in case of contact, rinse eyes thoroughly with water stop use and ask a doctor if irritation and redness develop and persist for more than 72 hours.

United States - English - NLM (National Library of Medicine)

tonghua ren-sheng-yuan biotechnology co., ltd - gastrodia elata whole (unii: zk2b063e7q) (gastrodia elata whole - unii:zk2b063e7q), alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. used for daily hand disinfection. - on children less than 2 months of age - on open skin wounds - in the eyes. in case of contact, rinse eyes thoroughly with water stop use and ask a doctor if irritation and redness develop and persist for more than 72 hours.

Israel - English - Ministry of Health

bristol-myers squibb (israel) limited - belatacept 25 mg/ml - powder for concentrate for infusion - belatacept - nulojix, in combination with corticosteroids and mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. it is recommended to add an interleukin (il)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - general hospital - syngo.plaza is a picture archiving and communication system intended to display, process, read, report, communicate, distribute, store, and archive digital medical images, including mammographic images. it supports the physician in diagnosis and treatment planning.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

tramadol hydrochloride 100mg/2ml